发明名称 Beta-Aminoacid-Derivatives As Factor Xa Inhibitors
摘要 The present invention relates to compounds of the formula I, in which R<SUP>0</SUP>; R<SUP>1</SUP>; R<SUP>2</SUP>; R<SUP>3</SUP>; R<SUP>4</SUP>; R<SUP>5</SUP>, R, Q; V, G and M have the meanings indicated in the claims. The compounds of the formula I are valuable pharmacologically active compounds. They exhibit a strong antithrombotic effect and are suitable, for example, for the therapy and prophylaxis of cardiovascular disorders like thromboemboic diseases or restenoses. They are reversible inhibitors of the blood clotting enzymes factor Xa (FXa) and/or factor VIIa (FVIIa), and can in general be applied in conditions in which an undesired activity of factor Xa and/or factor VIIa is present or for the cure or prevention of which an inhibition of factor Xa and/or factor VIIa is intended. The invention furthermore relates to processes for the preparation of compounds of the formula I, their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical preparations comprising them.
申请公布号 US2007179122(A1) 申请公布日期 2007.08.02
申请号 US20060469513 申请日期 2006.09.01
申请人 SANOFI-AVENTIS DEUTSCHLAND GMBH 发明人 URMANN MATTHIAS;NAZARE MARC;WEHNER VOLKMAR;MATTER HANS;BAUER ARMIN;WAGNER MICHAEL
分类号 A61K31/553;A61K31/381;A61K31/4178;A61K31/496;A61K31/4965;A61K31/5377;A61K31/54;A61K31/541;A61K31/55;A61K31/551;C07D265/32;C07D295/112;C07D403/02;C07D409/12;C07D409/14;C07D413/02;C07D413/12;C07D417/02;C07D419/12;C07K5/02 主分类号 A61K31/553
代理机构 代理人
主权项
地址